
ESHA Valuation
ESH Acquisition Corp
ESHA Relative Valuation
ESHA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ESHA is overvalued; if below, it's undervalued.
Historical Valuation
ESH Acquisition Corp (ESHA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of ESH Acquisition Corp (ESHA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:11.30
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
ESH Acquisition Corp. (ESHA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
ESH Acquisition Corp. (ESHA) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
ESH Acquisition Corp. (ESHA) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
ESH Acquisition Corp. (ESHA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
ESH Acquisition Corp. (ESHA) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
ESH Acquisition Corp (ESHA) has a current Price-to-Book (P/B) ratio of -32.42. Compared to its 3-year average P/B ratio of 43.02 , the current P/B ratio is approximately -175.37% higher. Relative to its 5-year average P/B ratio of 43.02, the current P/B ratio is about -175.37% higher. ESH Acquisition Corp (ESHA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -1.44%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.44% , the current FCF yield is about -100.00% lower.
-32.42
P/B
Median3y
43.02
Median5y
43.02
-5.09
FCF Yield
Median3y
-1.44
Median5y
-1.44
Competitors Valuation Multiple
The average P/S ratio for ESHA's competitors is 9.90, providing a benchmark for relative valuation. ESH Acquisition Corp Corp (ESHA) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ESHA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ESHA in the past 1 year is driven by Unknown.
People Also Watch

OM
Outset Medical Inc
13.010
USD
-0.84%

RAPT
RAPT Therapeutics Inc
29.350
USD
-2.85%

VIVK
Vivakor Inc
0.216
USD
-6.49%

TOI
Oncology Institute Inc
4.490
USD
+0.67%

CALC
CalciMedica Inc
2.990
USD
+1.01%

MDAI
Spectral AI Inc
1.980
USD
-7.04%

BRNS
Barinthus Biotherapeutics PLC
1.190
USD
-9.64%

INTS
Intensity Therapeutics Inc
0.620
USD
-15.06%

PXS
Pyxis Tankers Inc
2.680
USD
-1.11%
FAQ
Is ESH Acquisition Corp (ESHA) currently overvalued or undervalued?
ESH Acquisition Corp (ESHA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of ESH Acquisition Corp (ESHA) is between to according to relative valuation methord.








